4//SEC Filing
Byrne Thomas E 4
Accession 0001437749-18-000264
CIK 0001053691other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:03 PM ET
Size
5.4 KB
Accession
0001437749-18-000264
Insider Transaction Report
Form 4
Byrne Thomas E
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2018-01-02+10,000→ 10,000 totalExercise: $1.18Exp: 2028-01-02→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2018.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001663220
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:03 PM ET
- Size
- 5.4 KB